Singapore healthcare stocks: no more a defensive play as pandemic boost fades
SINGAPORE-LISTED healthcare players have witnessed retreating earnings and share prices this year, but analysts said that they continue to see good prospects for select stocks.
The iEdge Singapore All Healthcare Index delivered total returns of minus 2.5 per cent in the year to Monday (Nov 6). In comparison, the benchmark Straits Times Index was up 2.3 per cent over the same period.
These stocks may be correcting from their pandemic highs. The index generated total returns of 70.3 per cent in 2020, against an 8.1 per cent decline for the bourse’s blue-chip barometer.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
3M to cut dividend on health-care spin, losing aristocrat status
OCBC should be seen as ‘financial conglomerate’ unlike local banking peers, says chairman
HSBC CEO to retire; bank reports 1.7% lower Q1 profit of US$10.8 billion
McDonald's sales miss estimates as customers cut back spending
Coca-Cola raises annual organic sales forecast on global demand, higher prices
No extension to 6-month pause on DBS’ non-essential activities, but 1.8 times multiplier stays